Crossref
Nonstatin Lipid-Lowering Therapies Surge but Statins Remain Dominant
JAMA · 09.06.2026 · 335 (22) · 1922
DOI: 10.1001/jama.2026.6181 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 09.06.2026. Verfasst von Samantha Anderer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Anderer, S. (2026). Nonstatin Lipid-Lowering Therapies Surge but Statins Remain Dominant. JAMA, 335(22), 1922. https://doi.org/10.1001/jama.2026.6181
Vancouver
Anderer S. Nonstatin Lipid-Lowering Therapies Surge but Statins Remain Dominant. JAMA. 2026;335(22):1922. doi:10.1001/jama.2026.6181
BibTeX
@article{Anderer2026,
author = {Anderer, Samantha},
title = {Nonstatin Lipid-Lowering Therapies Surge but Statins Remain Dominant},
journal = {JAMA},
year = {2026},
volume = {335},
number = {22},
pages = {1922},
doi = {10.1001/jama.2026.6181}
}
EUVIMED